Published January 22, 2025
| Version v1
Model
Open
Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically 'actionable' signalling axis in triple negative breast cancer.
Creators
- Yang, Xue (Researcher)1
- Ma, Xiuquan (Researcher)1
- Croucher, David, R. (Researcher)2
- Nguyen, Elizabeth V. (Researcher)1
- Clark, Kimberley C. (Researcher)1
- Hu, Changyuan (Researcher)1
- Latham, Sharissa L. (Researcher)2
- Tianyue, Zhao (Researcher)1
-
Bayly-Jones, Charles
(Researcher)1
- Nguyen, Viet Chi Bao (Researcher)3
- Shin, Sung-Young (Researcher)1
- Nguyen, Lan K. (Researcher)1
- Cotton, Thomas R. (Researcher)1
- Chüeh, Anderly C. (Researcher)1
- Lim Kam Sian, Terry C.C. (Researcher)1
- Stratton, Margaret M. (Researcher)3
- Ellisdon, Andrew M. (Researcher)1
- Daly, Roger J. (Project leader)1
-
1.
Monash University, School of Biological Sciences
-
2.
Garvan Institute of Medical Research
-
3.
University of Massachusetts, Amherst
Description
AlphaFold models and associated metadata to accompany Yang et al, Nature Communcations, "Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically ‘actionable’ signalling axis in triple negative breast cancer" (2025).
Files
FINAL_camk1_peak1_b3a05.result.zip
Files
(26.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:41db2dfcbb1186c1b1cbd99c9b4d88dd
|
26.0 MB | Preview Download |
|
md5:01e0fcb953754e4d1e3278e6b5eb13de
|
388.7 kB | Download |